---
trial_id: 813
discovery_date: 2022-05-15 20:21:07.872988
date: 2022-05-15 20:21:07.872988
title: "Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy"
summary: |
  <b>Conditions</b>:    Multiple Sclerosis (MS);   Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Chronic Progressive;   Multiple Sclerosis Relapse;   Multiple Sclerosis Brain Lesion;   Multiple Sclerosis Benign<br /><b>Interventions</b>:    Drug: Clemastine Fumarate;   Drug: Placebo<br /><b>Sponsors</b>:    University of California, San Francisco;   United States Department of Defense<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05359653?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-05-04 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Conditions</b>:    Multiple Sclerosis (MS);   Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Chronic Progressive;   Multiple Sclerosis Relapse;   Multiple Sclerosis Brain Lesion;   Multiple Sclerosis Benign<br /><b>Interventions</b>:    Drug: Clemastine Fumarate;   Drug: Placebo<br /><b>Sponsors</b>:    University of California, San Francisco;   United States Department of Defense<br /><b>Not yet recruiting</b>